$PROG News
Last published 3y ago
- 3y agoPROGProgenity Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 4y agoPROGProgenity Announces Successful Transfer of Liquid Biopsy TechnologiesGlobeNewswireSAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG) today announced it has completed the divesture of a collection of novel, discovery-stage biochemical and bioinformatics technologies, including single-molecule detection, which a
- 4y agoPROGProgenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc.GlobeNewswireSAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG) today announced that it will report first quarter ended March 31, 2022 financial results on Tuesday, May 10, 2022 after the close of financial markets. Progenity's management wil
- 4y agoPROGProgenity Appoints Paul Shabram to Lead Technical Operations of the Company's Ingestible Drug/Device PlatformsGlobeNewswireSAN DIEGO, April 25, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced the appointment of Paul Shabram, MBA, as Senior
- 4y agoPROGProgenity to Become Biora Therapeutics as it Completes TransformationGlobeNewswireSAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that it will change its name to Biora Therapeut
- 4y agoPROGProgenity Announces Two Poster Presentations at Controlled Release Society 2022GlobeNewswireSAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced the acceptance of two abstracts presenting prec
- 4y agoPROGProgenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewswireAccelerated Company Transformation Toward Oral Delivery of Biotherapeutics and Targeted Therapeutics Programs Progressed Company's Targeted Therapeutics Clinical Programs with Initiation of Clinical Device Performance Study in Patients with Ulcerative
- 4y agoBJDXENSVIASMULN+1Thinking about buying stock in Mullen Automotive, Enservco, Bluejay Diagnostics, Integral Ad Science, or Progenity?PR NewswireNEW YORK, March 21, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MULN, ENSV, BJDX, IAS, and PROG.
- 4y agoPROGProgenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate UpdateGlobeNewswireSAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that it will report financial results for the f
- 4y agoPROGProgenity Progresses its Drug Delivery System Clinical Device Performance StudiesGlobeNewswireClinical Device Performance Study in Healthy Volunteers Demonstrated Accurate Localization and Delivery A Clinical Device Performance Study in Patients with Ulcerative Colitis is Now Recruiting SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- Progen
- 4y agoPROGProgenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022GlobeNewswireSAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced the acceptance of three abstracts on the treatme
- 4y agoPROGProgenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO'22GlobeNewswireSAN DIEGO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today shared two poster presentations that were presented during
- 4y agoPROGProgenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of GastroenterologyGlobeNewswireSAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today shared an oral presentation that was delivered by Dr. Bram
- 4y agoPROGProgenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional PatentGlobeNewswireSAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, today announced the award of another new patent related to its single-molecule detection assay platform under development. The USPTO has is
- 4y agoPROGProgenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of GastroenterologyGlobeNewswireSAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that patient data on indicators of efficacy in t
- 4y agoPROGProgenity Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 4y agoPROGProgenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO'22GlobeNewswireSAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that two presentations with patient data on indi
- 4y agoPROGProgenity to Participate in the H.C. Wainwright BIOCONNECT Virtual ConferenceGlobeNewswireSAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that the company will participate in a pre-recor
- 4y agoPROGProgenity Completes Exit from Laboratory Business with Sale of Affiliate LabGlobeNewswireSAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced it has successfully closed the business divestit
- 4y agoPROGProgenity Announces New Patent for Single-Molecule Detection TechnologyGlobeNewswireSAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a new patent related to its single-molecule detection plat
- 4y agoINOPROGAURAMC+3Meme Stocks Head for Worst Day Since March as Risk-Off RagesBloomberg
- 4y agoAMCPROGAAPLLCID+2Retail Traders Jump Back Into Tiny Biotechs Ahead of HolidayBloomberg
- 4y agoPROGProgenity Strengthens its Liquidity PositionGlobeNewswireCompany received more than $44 million in warrant exercises since August 2021. Current liquidity position provides runway to achieve critical research and development milestones through 2022. SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Progenity
- 4y agoCEINAKDPROGRLX+1Thinking about buying stock in Camber Energy, Naked Brand, Progenity, Vale SA, or RLX Technology?PR NewswireNEW YORK, Nov. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEI, NAKD, PROG, VALE, and RLX. To
- 4y agoCLOVLCIDPROGTLRY+1Thinking about buying stock in Lucid Group, Clover Health, Progenity, Tilray, or Vipshop Holdings?PR NewswireNEW YORK, Nov. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LCID, CLOV, PROG, TLRY, and VIPS.
- 4y agoGOEVPROGVIRYQ+1Thinking about buying stock in 17 Education & Technology, Progenity, Canoo, Vir Biotechnology, or Zosano Pharma?PR NewswireNEW YORK, Nov. 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for YQ, PROG, GOEV, VIR, and ZSAN. To
- 4y agoKZRPLBYPROGRXT+1Thinking about buying stock in Kezar Life Sciences, SCYNEXIS, Plby Group, Progenity, or Rackspace Technology?PR NewswireNEW YORK, Nov. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for KZR, SCYX, PLBY, PROG, and RXT. To
- 4y agoPROGProgenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ConferenceGlobeNewswireSAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conf
- 5y agoPROGProgenity Provides Corporate Update and Reports Third Quarter 2021 Financial ResultsGlobeNewswireAdded important patents further protecting the company's therapeutic delivery technologies Added strong biotherapeutics capabilities to management team and board of directors Implemented cost-cutting measures expected to result in approximately $14
- 5y agoPROGProgenity Appoints Adi Mohanty as Chief Executive OfficerGlobeNewswireSAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, today announced the appointment of Adi Mohanty as Chief Executive Officer of the company, effective November 8, 2021. Mr. Mohanty also join
- 5y agoPROGProgenity Announces Appointment of Jill Howe to its Board of DirectorsGlobeNewswireSAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, announced the appointment of Jill Howe to its board of directors effective November 3, 2021. Ms. Howe was also appointed chairperson of the
- 5y agoPROGProgenity to Report Third Quarter 2021 Financial Results and Provide Corporate UpdateGlobeNewswireSAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, today announced that it will report third quarter 2021 financial results on Wednesday, November 10, 2021 after the close of financial marke
- 5y agoEDSAPFEPLUGPROG+1Thinking about buying stock in Pfizer, Phillips 66, Plug Power, Progenity, or Edesa Biotech?PR NewswireNEW YORK, Oct. 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, PSX, PLUG, PROG, and EDSA. T
- 5y agoPROGProgenity Reduces Outstanding Debt by $20.175 Million Through a Private Exchange of $20.175 Million of Its 7.25% Convertible Senior Notes Due 2025 for Shares of Common StockGlobeNewswireSAN DIEGO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. ("Progenity") (NASDAQ:PROG), an innovative biotechnology company, today announced that it has entered into privately negotiated agreements with certain non-affiliated holders of its existing
- 5y agoPFEPROGTTSLA+1Thinking about buying stock in AT&T, Tesla, Pfizer, Progenity, or Energous Corp?PR NewswireNEW YORK, Oct. 25, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for T, TSLA, PFE, PROG, and WATT. To
- 5y agoCRTDIZEAPROGSENS+1Thinking about buying stock in Creatd, Sundial Growers, Progenity, IZEA Worldwide, or Senseonics Holdings?PR NewswireNEW YORK, Oct. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRTD, SNDL, PROG, IZEA, and SENS.
- 5y agoHXPLUGPROGSKLZ+1Thinking about buying stock in Xiaobai Maimai, Progenity, ContextLogic, Plug Power, or Skillz?PR NewswireNEW YORK, Oct. 21, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HX, PROG, WISH, PLUG, and SKLZ. To
- 5y agoFLMDXPROGTLRY+1Thinking about buying stock in Progenity, Ford, Tilray, LumiraDx, or Tencent Music Entertainment?PR NewswireNEW YORK, Oct. 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, F, TLRY, LMDX, and TME. To
- 5y agoADMPAVIRBTUIO+1Thinking about buying stock in Progenity, Atea Pharmaceuticals, Peabody Energy, Adamis Pharmaceuticals, or Ion Geophysical?PR NewswireNEW YORK, Oct. 19, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, AVIR, BTU, ADMP, and IO. To
- 5y agoPROGProgenity to Participate in Crohn's & Colitis Foundation's Fourth Annual IBD Innovate ConferenceGlobeNewswireSAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, announced today that the company will participate in the fourth annual IBD Innovate Product Development for Crohn's & Colitis virtual confe
- 5y agoFFAMILCIDPROG+1Thinking about buying stock in Farmmi, Progenity, Ford, Virgin Galactic, or Lucid Group?PR NewswireNEW YORK, Oct. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FAMI, PROG, F, SPCE, and LCID. To
- 5y agoCLSKPROGSPCETIGR+1Thinking about buying stock in CleanSpark, Virgin Galactic, Progenity, Up Fintech, or Waitr?PR NewswireNEW YORK, Oct. 15, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSK, SPCE, PROG, TIGR, and WTRH.
- 5y agoHNRGLOKBPROGTALK+1Thinking about buying stock in Hallador Energy, Progenity, Tata Motors, Live Oak Acquisition, or Talkspace?PR NewswireNEW YORK, Oct. 14, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HNRG, PROG, TTM, LOKB, and TALK. T
- 5y agoNRBOPLUGPROGTTM+1Thinking about buying stock in Progenity, Neurobo Pharmaceuticals, Vistra Corp, Plug Power, or Tata Motors?PR NewswireNEW YORK, Oct. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, NRBO, VST, PLUG, and TTM. T
- 5y agoPROGProgenity Announces Several Patents Granted by USPTO, Strengthening the Company's Intellectual Property Position in Ingestible Therapeutics TechnologiesGlobeNewswireSAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has issued four patents related to its ingestible technologies f
- 5y agoFAMIPROGRRDSOFI+1Thinking about buying stock in Progenity, Farmmi, RR Donnelley & Sons, SoFi Technologies, or Voyager Therapeutics?PR NewswireNEW YORK, Oct. 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, FAMI, RRD, SOFI, and VYGR.
- 5y agoBTBTCEIMRONAOV+1Thinking about buying stock in Camber Energy, NanoVibronix, Progenity, Marathon Oil, or Bit Digital?PR NewswireNEW YORK, Oct. 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEI, NAOV, PROG, MRO, and BTBT. To
- 5y agoAEHRAGRXFMIC+1Thinking about buying stock in Ford Motor, Macquarie Infrastructure, Progenity, Agile Therapeutics, or Aehr Test Systems?PR NewswireNEW YORK, Oct. 8, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for F, MIC, PROG, AGRX, and AEHR. To s
- 5y agoABUSNFEPROGTTM+1Thinking about buying stock in Tata Motors, New Fortress Energy, Arbutus Biopharma, US Well Services, or Progenity?PR NewswireNEW YORK, Oct. 7, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTM, NFE, ABUS, USWS, and PROG. To
- 5y agoPROGProgenity Announces Closing of $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq RulesGlobeNewswireSAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. ("Progenity") (NASDAQ:PROG), an innovative biotechnology company, today announced the closing of its previously announced registered direct offering of 13,333,334 shares of the Company's comm